Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
An AI algorithm has slightly outperformed neurologists at identifying or ruling out Alzheimer’s disease from MRI brain scans combined with demographic information and neuropsychological test results.
Scale AI is funding eight research projects focused on helping Canada respond to the ongoing COVID-19 pandemic, an investment that adds up to $3.4 million.
An unlikely team at Berkeley Lab has created a text-mining tool that may help scientists of all disciplines tame and tap the presently blinding blizzard of COVID-19 papers.
IBM has launched a blockchain-based network for healthcare organizations and government agencies looking to quickly find and hire alternative supply-chain sources during the public-health crisis set off by the COVID-19 outbreak.
For champions of AI in healthcare, the COVID-19 crisis affords an unignorable opportunity to trumpet the technology’s current contributions while directing attention to its potential for helping fight public-health crises to come.
